Effect of fudosteine, a cysteine derivative, on blood flow of tracheal microvasculature increased by airway inflammation

Citation
K. Takahashi et al., Effect of fudosteine, a cysteine derivative, on blood flow of tracheal microvasculature increased by airway inflammation, ENV TOX PH, 10(3), 2001, pp. 89-93
Citations number
25
Categorie Soggetti
Pharmacology & Toxicology
Journal title
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
ISSN journal
13826689 → ACNP
Volume
10
Issue
3
Year of publication
2001
Pages
89 - 93
Database
ISI
SICI code
1382-6689(200107)10:3<89:EOFACD>2.0.ZU;2-T
Abstract
We examined the effect of fudosteine, a cysteine derivative, on blood flow of tracheal microvasculature increased by airway inflammation. Airway infla mmation was elicited by sulfur dioxide (SO2) exposure for 2 weeks in rabbit s. Each drug (500 mg/kg, p.o.) or 0.5% carboxymethylcellulose-Na (control g roup) was daily administered just before SO2 exposure. After final SO2 expo sure was finished, blood flow of tracheal microvasculature was measured by blood perfusion monitor. Fudosteine or S-carboxymethylcysteine (S-CMC) sign ificantly suppressed blood flow of tracheal microvasculature increased by S O2 exposure. However, no effect of fudosteine was observed on the pharmacol ogical microvascular response in trachea of SO2-exposed rabbits. On the oth er hand, fudosteine or S-CMC scavenged superoxide anion generated from rat neutrophils, and enzymatically generated from xanthine oxidase-acetaldehyde reaction. The results suggest that suppressive action in increased trachea l blood flow of fudosteine is due to anti-inflammatory activity, at least i n part, via scavenging of superoxide anion. (C) 2001 Elsevier Science B.V. All rights reserved.